The Effects of Ezetimibe/Simvastatin Versus Simvastatin Alone on Platelet and Inflammatory Biomarkers in Patients With the Metabolic Syndrome.
Phase of Trial: Phase IV
Latest Information Update: 31 Dec 2014
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Simvastatin
- Indications Metabolic syndrome
- Focus Biomarker; Pharmacodynamics
- 12 Jun 2012 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 12 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Oct 2009 Planned end date changed from 1 Jun 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.